It was reported that stem-like CD8+ T cells that express TCF1 remained responsive to checkpoint blockade therapy, suggesting that the state of T cells, in addition to the number and spatial distribution of T cells, was critical for the induction of effective tumor immunity9,10,13,57. The gene discussed is CD8A; the disease is neoplasm.